Any pregnant, HIV positive woman exposed to antiretroviral drugs during pregnancy is eligible to enroll. Registration is voluntary. Health professionals are strongly encouraged to enroll their antiretroviral-exposed pregnant patients into the Registry as early in the pregnancy as possible, preferably before prenatal testing is done.